The woman who tested positive for Ebola in Nigeria and was evacuated to Switzerland for treatment has been discharged from hospital after making a full recovery.

She was discharged from Geneva University Hospitals on Wednesday, after medical personnel confirmed her recovery, Reuters reported on Thursday, quoting a statement from the hospital.

“After the medical team confirmed her full recovery, the cantonal physician authorised the patient being treated for Ebola virus disease to leave the Geneva University Hospitals (HUG) on 11 November 2026,” the hospital said.

The Uganda-born woman and her husband, a Swiss diplomat, were evacuated from Nigeria to Switzerland on 26 October. Her evacuation was confirmed by the Minister of Health and Social Welfare, Muhammad Pate.

The patient had returned to Abuja from Uganda on 3 October. She developed symptoms days later and was admitted to a private health facility before the Nigeria Centre for Disease Control and Prevention (NCDC) was notified. Laboratory tests confirmed the infection on 20 October.

Nigeria continues Ebola surveillance

The NCDC’s latest Ebola situation dashboard, updated on 12 November with data as of 11 November, lists one confirmed case, no deaths and seven negative cases.

It also shows that 62 contacts linked to the confirmed case have been identified. Of these, 52 have completed their mandatory 21-day follow-up, while 10 remain under monitoring.

The NCDC said its response includes contact tracing, investigation of reported alerts, laboratory testing, infection prevention and control measures, and surveillance at the country’s points of entry.

On 11 November, NCDC disclosed that Nigeria recorded no additional confirmed Ebola cases since the imported infection was confirmed.

The agency has urged healthcare workers to remain vigilant, ask patients about their travel and exposure histories, and promptly report suspected cases to public health authorities.

READ ALSO: Ebola: Nigeria records no new cases 21 days after imported infection – NCDC

Regional outbreak continues

The situation in Nigeria is part of a wider outbreak of Bundibugyo virus disease affecting parts of Africa.

In its latest situation update published on 6 November, the World Health Organisation (WHO) said the DRC had recorded 10,668 confirmed cases and 5,198 deaths as of 3 November, across 67 health zones in eight provinces.

Kenya had recorded nine confirmed cases and two deaths, while Nigeria had reported one imported case. WHO said there had been no new confirmed cases in Kenya or Nigeria since its previous update.

PREMIUM TIMES journalist Mariam Ileyemi has emerged as the third-prize winner in the Nigeria AMR Media Awards (NAMA), recognising her reporting on antimicrobial resistance (AMR).

The NAMA is a national category of the 2026 Global AMR Media Awards (GAMA), which recognises journalists and other media professionals whose work raises awareness of drug-resistant infections and promotes action against the growing public health threat.

The 2026 awards received 382 entries from four global regions, with Africa accounting for 193 submissions. Asia-Pacific followed with 134 entries, while Europe and the Americas recorded 28 and 27 entries, respectively. Nigeria submitted 96 entries for the global and national competitions, representing about a quarter of the total submissions.

Ms Ileyemi was recognised for her report examining the gender dimensions of AMR, including how gender-based violence, social inequalities and barriers to healthcare affect women’s exposure to drug-resistant infections and access to treatment.

In the report, published in March 2026, she highlighted calls by health experts for gender-responsive policies to address antimicrobial resistance.

The recognition adds to her reporting on AMR. In November 2024, she collaborated with Nike Adebowale-Tambe, the PREMIUM TIMES Head of Health and Development Desk, on a special investigation examining the experiences of Nigerians affected by drug-resistant infections and the challenges they face when medicines fail.

In the NAMA category, Kazeem Biriowo of Nigerian Tribune won first prize, while Julian Adetinuyo of News Scope Africa came second.

Seven other journalists received special mentions: Folashade Akpan of the News Agency of Nigeria, Chioma Obinna of Vanguard, Helen Oji Emmanuel of Blueprint, Fatima Saka of DistinctNews, Chinyere Okorafor of Nigeria Health Times, Laide Akinboade of Daily Asset and Odimmegwa John Peter of New Africa Horizon.

The winners in the Nigerian category will receive certificates and cash prizes supported by the Art for Health Initiative, a non-profit organisation.

The awards were announced on 11 November during the Sixth Global Media Forum on AMR, ahead of World Antimicrobial Resistance Awareness Week, observed annually from 18 to 24 November.

Nigeria is scheduled to host the Fifth Global High-Level Ministerial Conference on AMR in Abuja from 6 to 8 December 2026. The conference, the first of its kind to be held on African soil, is expected to bring together government representatives and other stakeholders to strengthen global action against antimicrobial resistance.

Other Nigerian winners

Other Nigerian journalists also received recognition in the global award categories.

In the category for reporting on the Fifth High-Level Ministerial Conference on AMR, Annabel Nwachukwu of the Federal Radio Corporation of Nigeria won first prize, followed by Edward Samuel Ikpete of Voice of Nigeria in second place and Doris Obinna of The Sun in third. Alice Etuka of The Fact Daily received a special mention.

In the People’s Reporting category, Isioma Appiah-Yeboah of Clean Beat Radio won first prize, Racheal Abujah of NAN won second, and Helen Shikanda, a Kenyan, came third. Princess Ekwi-Ajide of the Anambra Broadcasting Service, Smith Nwokocha of Port Harcourt Wakawaka Blog and Chioma Vivian James of True Verdict received special mentions.

Patience Ihejirika of Leadership Newspaper and Benedict Ifeanyi Chukwu of Kaftan TV also received special mentions in the Africa category.

The Global AMR Media Awards are organised by the Global AMR Media Alliance, a network of media professionals working to raise awareness of antimicrobial resistance and promote its visibility within global health security and the United Nations Sustainable Development Goals.

Media coverage of AMR

Speaking after the announcement, Shobha Shukla, chairperson of the Global AMR Media Alliance, congratulated Nigerian journalists and commended Ojoma Akor, founding chairperson of the Nigeria AMR Media Alliance, for highlighting the effects of AMR and strengthening media efforts to address the problem.

Ms Shukla said AMR was not merely a medical or scientific issue but also a societal and development challenge that required action beyond laboratories and hospitals.

“We need an informed public, accountable governments, and responsible practices across human, animal, and environmental health,” she said.

She said the media has the power to connect these issues, amplify the experiences of affected communities and turn public awareness into action.

Ms Shukla urged journalists to move beyond reporting AMR solely as a health news issue and help build public support for responsible antimicrobial use and stronger health systems.

Ms Akor, in her comments, described the inaugural NAMA awards as an important milestone for health and science journalism in Nigeria, noting that AMR had received insufficient attention in newsrooms despite its implications for public health, healthcare delivery, food security and national development.

She said the awards recognised journalism’s role in making an often-unseen public health threat visible, translating complex scientific evidence into accessible information, amplifying the experiences of affected communities and holding institutions accountable.

“As an alliance, we remain committed to building the capacity of journalists, encouraging investigative and solutions-oriented reporting, and ensuring that AMR receives the sustained attention it deserves,” she said.

Chidera Rosecamille Aneke, founder of the Art for Health Initiative, said AMR is one of the organisation’s focal areas and explained that its support for the NAMA awards was intended to encourage innovative storytelling.

“AMR is one of our organisation’s focal areas, and we are glad to support the NAMA awards to push innovative storytelling to communicate AMR in ways the audience can understand,” she said.

She said the initiative works at the intersection of storytelling, media and the arts to promote public understanding and action on critical health issues.

Understanding antimicrobial resistance

Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites change over time and no longer respond effectively to medicines used to treat infections. This makes infections harder to treat and increases the risk of severe illness and death.

The problem affects human and animal health, food production and the environment, making it a One Health concern.

Nigeria’s National Action Plan on Antimicrobial Resistance 2024–2028 cites estimates that 64,500 deaths in the country were directly attributable to AMR in 2019, while 263,400 deaths were associated with it. The country has also acknowledged surveillance gaps that make it difficult to establish the full scale of drug-resistant infections.

About Mariam Ileyemi

Mariam Ileyemi is a Nigerian journalist on the Health and Development Desk at PREMIUM TIMES. Her reporting covers antimicrobial resistance, disease prevention, and primary healthcare.

She was named PREMIUM TIMES Reporter of the Year 2025 and is a fellow of the Africa Health Communications Fellowship and Media-EIS Fellowship, among others.

She was recently nominated for the Outstanding Health Investigation Award at the Private Sector Health Alliance of Nigeria (PSHAN) Annual Awards. She is also a recipient of the Mamman Marshall Scholarship for Women in Journalism.